Summary of post-treatment CAPS score changes from clinical trials with psychotherapies. by Filip Stanicic (17808254)

Subjects:

Arctigenin decreased proliferation in colorectal cancer cells with no significant effect on normal cells. by Xiang-Fan Chen (13932983)

(a) M-K test of annual average water level in Caspian Sea (unformatted fit (UF) and underidentification bias (UB) is positive and reverse order in the time series respectively; ɑ i... by Zihao Duan (17403792)

Subjects:

(a) Surface area and volume change with water level; (b) Topographic changes in the Caspian Sea. by Zihao Duan (17403792)

Subjects:

Summary of significant single-arm time effect. by Wensheng Xiao (16557866)

<i>Porphyromonas gingivalis</i> LPS pretreated by ozone ultrafine bubble water induces decreased TLR2 activation. by Mana Endo (22430706)

Trends of incident opioid users, L-TOT users, and L-TOT discontinuers between 2009 and 2013. by Qian Cai (112039)

Subjects:

The yearly numerator, denominator and rate of incident opioid users, L-TOT users and L-TOT discontinuers from 2009 to 2019. by Qian Cai (112039)

Subjects:

Incidence rate ratios of negative binominal regression models for yearly rates of incident opioid users, L-TOT users and L-TOT discontinuers during 2009–2013 and 2015–2019. by Qian Cai (112039)

Subjects:

Demographic, comorbidity, concurrent drug, and opioid characteristics, among L-TOT users and L-TOT discontinuers between 2009–2019. by Qian Cai (112039)

Subjects:

Analysis of the Nugent score before (T=0) and after (T=1) the use of the vaginal gel. Number of participants and respective percentages of Nugent scores before and after the intervention. A statistically significant decrease in Nugent scores was observed after the intervention (p value =0.0047). by Adriana Bittencourt Campaner (21175462)

“…Number of participants and respective percentages of Nugent scores before and after the intervention. A statistically significant decrease in Nugent scores was observed after the intervention (p value =0.0047).…”

Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications. by Filip Stanicic (17808254)

Subjects:

Post-treatment CAPS score changes from clinical trials with off-label PTSD medications. by Filip Stanicic (17808254)

Subjects:

Contains R code utilized in the analyses. by Arttu Autio-Kimura (20454681)

Subjects:

Sex-based differences for combinations of brain regions and cell types, based on Mann-Whitney U-test. by Arttu Autio-Kimura (20454681)

Subjects:

Bootstrapped spearman correlations from a randomly selected subset of male sample donor originating samples (n = 493). by Arttu Autio-Kimura (20454681)

Subjects:

Spearman correlations between the age of the sample donor (20–70 years) and estimated proportions of neuronal, glial, and endothelial cells. by Arttu Autio-Kimura (20454681)

Subjects:

Box plots for subsets of female originating samples, displaying the distributions of the proportions of neuronal, glial, and endothelial cells. by Arttu Autio-Kimura (20454681)

Subjects:

Box plots for subsets of male originating samples, displaying the distributions of the proportions of neuronal, glial, and endothelial cells. by Arttu Autio-Kimura (20454681)

Subjects:

Box plot displaying the distributions of the deconvolution derived proportions of cell types. by Arttu Autio-Kimura (20454681)

Subjects: